Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax
Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fi...
Saved in:
Published in | Journal of Huazhong University of Science and Technology. Medical sciences Vol. 35; no. 5; pp. 672 - 678 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Wuhan
Huazhong University of Science and Technology
01.10.2015
Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China |
Subjects | |
Online Access | Get full text |
ISSN | 1672-0733 1993-1352 |
DOI | 10.1007/s11596-015-1488-0 |
Cover
Abstract | Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax. |
---|---|
AbstractList | Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells (HSCs) may be the key point to reverse liver fibrosis. At present, anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study, the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay, cell cycle and apoptosis were analyzed by flow cytometry, and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/mL, the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time (P < 0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner (P < 0.01). The apoptosis rates of the HSCs treated with 8, 4 and 2 μg/mL kinetin (25.62% ± 2.21%, 15.31% ± 1.9% and 6.18% ± 1.23%, respectively) were increased significantly compared with the control group (3.81% ± 0.93%) (P < 0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak (sub-G1 peak), and with the increase of kinetin concentrations, the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2, and up-regulate the expression of Bax, leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax, and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax. Summary Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells (HSCs) may be the key point to reverse liver fibrosis. At present, anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study, the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay, cell cycle and apoptosis were analyzed by flow cytometry, and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/mL, the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time ( P <0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner ( P <0.01). The apoptosis rates of the HSCs treated with 8, 4 and 2 μg/mL kinetin (25.62%±2.21%, 15.31%±1.9% and 6.18%±1.23%, respectively) were increased significantly compared with the control group (3.81%±0.93%) ( P <0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak (sub-G1 peak), and with the increase of kinetin concentrations, the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2, and up-regulate the expression of Bax, leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax, and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax. Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax. |
Author | 张振纲 邹婕 黄莹 吴亮 |
AuthorAffiliation | Department of Infectious Diseases, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Wuhan Institute of Skin Disease Prevention and Control Wuhan 430030, China |
AuthorAffiliation_xml | – name: Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China |
Author_xml | – sequence: 1 fullname: 张振纲 邹婕 黄莹 吴亮 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26489620$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URD_gB3BBFldkOk5iJzm2C7QVlUB8nC3bcVIvqR1sr7r7K_jLdTalSBx6mpHnfeYdzxyjA-edQeg1hfcUoD6NlLKWE6CM0KppCDxDR7RtS0JLVhzknNcFgbosD9FxjGsAVvOieoEOC141LS_gCP35bJ1J1uErd2OVTRF_DX60vQkyWe-w7_GlmXKu8fdkxlEmg1c5Rqx2mUkmhM2U-WH_ilc7PRosXZdr3UabiM8mPyUf7R744O8cCWbY5D4z8202mT3O9UiK03O5fYme93KM5tVDPEE_P338sbok118urlZn10RXUCeioaOmYWC4hvxJWdBOK8lNA1JDU1VMtY1qNQdVlqxrW9q0tFes6iivlNZdeYLeLX3vpOulG8Tab4LLjiKtd7-67VYJU-TFAgMKWf1mUU8bdWs6MQV7K8NO_N1jFtBFoIOPMZj-UUJBzLcSy61EbinmW4mZqf9jtE37racg7fgkWSxkzC5uMOHf9E9Bbx_sbrwbfmfucUbOeUlrzpryHplwtGk |
CitedBy_id | crossref_primary_10_1007_s11596_017_1699_7 crossref_primary_10_3390_nu14071495 crossref_primary_10_1016_j_fbio_2023_103454 crossref_primary_10_1007_s12032_020_1338_1 crossref_primary_10_1016_j_taap_2023_116655 crossref_primary_10_1155_2018_2768120 |
Cites_doi | 10.1016/j.bpg.2011.02.005 10.1152/ajpgi.00451.2010 10.1007/978-1-60327-409-8_1 10.1104/pp.104.900160 10.1016/j.biopha.2012.10.002 10.1016/j.jhep.2011.09.024 10.1016/j.cld.2008.07.011 10.1186/1472-6882-14-449 10.1016/j.cgh.2013.01.005 10.1186/1471-2407-10-238 10.2741/reeves 10.1053/j.gastro.2008.03.003 10.1152/physrev.00013.2007 10.1172/JCI24282 10.1093/hmg/ddh046 10.1016/j.cbi.2011.07.001 10.1055/s-2008-1040454 10.1046/j.1365-2184.2003.00266.x 10.1136/gutjnl-2014-306842 10.1172/JCI1018 10.1016/S0925-4439(97)00028-8 10.1016/S0168-8278(02)00429-4 10.1159/000201257 10.1016/S0014-2999(03)01528-0 10.1007/s00204-014-1448-7 10.1111/jgh.1998.13.s1.33 10.1016/S0021-9258(18)81686-6 10.3892/mmr.2012.1076 |
ContentType | Journal Article |
Copyright | Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2015 Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2015 – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/s11596-015-1488-0 |
DatabaseName | 中文科技期刊数据库 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax |
EISSN | 1993-1352 |
EndPage | 678 |
ExternalDocumentID | tjykdxxb_e201505010 26489620 10_1007_s11596_015_1488_0 666317658 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: This study was supported by a grant from Hubei Natural Science Foundation of China funderid: (2013CFB135) |
GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJNI ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I DPUIP EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA ABQSL H13 AAYXX ADHKG AGQPQ CITATION CGR CUY CVF ECM EIF NPM 4A8 93N PSX |
ID | FETCH-LOGICAL-c407t-c0d1e850e6c0672a21dcba6e80ac08445b98b9c60b335d991891fb54d164bccd3 |
IEDL.DBID | AGYKE |
ISSN | 1672-0733 |
IngestDate | Thu May 29 04:06:47 EDT 2025 Thu Apr 03 06:58:39 EDT 2025 Tue Jul 01 00:21:58 EDT 2025 Thu Apr 24 23:01:22 EDT 2025 Fri Feb 21 02:37:17 EST 2025 Wed Feb 14 10:28:39 EST 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 5 |
Keywords | kinetin apoptosis liver fibrosis hepatic stellate cell proliferation |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c407t-c0d1e850e6c0672a21dcba6e80ac08445b98b9c60b335d991891fb54d164bccd3 |
Notes | Apoptosis cytometry regulating inhibit inducing cirrhosis markedly stellate manner regulate Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax. Zhen-gang ZHANG, Jie ZOU,Ying HUANG , Liang WU (1Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China) 42-1679/R |
PMID | 26489620 |
PageCount | 7 |
ParticipantIDs | wanfang_journals_tjykdxxb_e201505010 pubmed_primary_26489620 crossref_primary_10_1007_s11596_015_1488_0 crossref_citationtrail_10_1007_s11596_015_1488_0 springer_journals_10_1007_s11596_015_1488_0 chongqing_primary_666317658 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Wuhan |
PublicationPlace_xml | – name: Wuhan – name: China |
PublicationSubtitle | Medical Sciences |
PublicationTitle | Journal of Huazhong University of Science and Technology. Medical sciences |
PublicationTitleAbbrev | J. Huazhong Univ. Sci. Technol. [Med. Sci.] |
PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Edition |
PublicationTitle_FL | Journal of Huazhong University of Science and Technology(Medical Science) |
PublicationYear | 2015 |
Publisher | Huazhong University of Science and Technology Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China |
Publisher_xml | – name: Huazhong University of Science and Technology – name: Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China |
References | Greenwel, Rojkind (CR24) 1997; 1361 Geng, Wang, Sun (CR30) 2015 Siddiqui, Ahad, Ahsan (CR35) 2015; 89 Slaugenhaupt, Mull, Leyne (CR20) 2004; 13 Hsiao, Shen, Lin (CR19) 2003; 465 Mormone, George, Nieto (CR1) 2011; 193 Bataller, Brenner (CR2) 2005; 115 Friedman (CR26) 1990; 10 Kong, Zhang, Zhang (CR34) 2013; 67 Ellis, Mann (CR9) 2012; 56 Iredale, Benyon, Pichering (CR25) 1998; 102 Loo (CR33) 2011; 682 Friedman (CR5) 2008; 88 Kowalska (CR18) 1992; 51 Lee, Wallace, Friedman (CR14) 2015; 64 Rockey (CR10) 2013; 11 Ishii, Hori, Sakai (CR21) 2002; 13 Reeves, Friedman (CR3) 2002; 7 Zhang, Tian, Zhou (CR22) 2006; 14 Vermeulen, Van Bockstaele, Berneman (CR32) 2003; 36 Amasino (CR17) 2005; 138 Lee, Friedman (CR6) 2011; 25 Friedman, Roll, Boyles (CR28) 1989; 264 Gressner, Bachem (CR27) 1995; 56 Fang, Li, An (CR12) 2011; 27 Friedman (CR15) 2003; 38 Tao, Yan, Zhou (CR29) 2014; 18 Fallowfield (CR16) 2011; 300 (CR8) 2002; 4 Liu, Wei, Huo (CR13) 2012; 6 Friedman (CR4) 2008; 134 Vanamala, Reddivari, Radhakrishnan (CR31) 2010; 10 Arthur, Mann, Iredale (CR23) 1998; 13 (CR7) 2009; 25 Rockey (CR11) 2008; 12 Y Ishii (1488_CR21) 2002; 13 K Vermeulen (1488_CR32) 2003; 36 DT Loo (1488_CR33) 2011; 682 J Vanamala (1488_CR31) 2010; 10 JA Fallowfield (1488_CR16) 2011; 300 R Amasino (1488_CR17) 2005; 138 D Kong (1488_CR34) 2013; 67 SL Friedman (1488_CR4) 2008; 134 SL Friedman (1488_CR28) 1989; 264 YY Tao (1488_CR29) 2014; 18 WA Siddiqui (1488_CR35) 2015; 89 AM Gressner (1488_CR27) 1995; 56 R Bataller (1488_CR2) 2005; 115 SA Slaugenhaupt (1488_CR20) 2004; 13 (1488_CR8) 2002; 4 L Liu (1488_CR13) 2012; 6 G Hsiao (1488_CR19) 2003; 465 DC Rockey (1488_CR11) 2008; 12 E Kowalska (1488_CR18) 1992; 51 YA Lee (1488_CR14) 2015; 64 SL Friedman (1488_CR26) 1990; 10 HL Reeves (1488_CR3) 2002; 7 MJ Arthur (1488_CR23) 1998; 13 ZG Zhang (1488_CR22) 2006; 14 Y Geng (1488_CR30) 2015 UE Lee (1488_CR6) 2011; 25 (1488_CR7) 2009; 25 EL Ellis (1488_CR9) 2012; 56 SL Friedman (1488_CR15) 2003; 38 JP Iredale (1488_CR25) 1998; 102 SM Fang (1488_CR12) 2011; 27 DC Rockey (1488_CR10) 2013; 11 E Mormone (1488_CR1) 2011; 193 SL Friedman (1488_CR5) 2008; 88 P Greenwel (1488_CR24) 1997; 1361 17064479 - Zhonghua Gan Zang Bing Za Zhi. 2006 Oct;14(10):780-2 2732246 - J Biol Chem. 1989 Jun 25;264(18):10756-62 12681440 - Eur J Pharmacol. 2003 Apr 4;465(3):281-7 11801528 - Cell Growth Differ. 2002 Jan;13(1):19-26 12814430 - Cell Prolif. 2003 Jun;36(3):131-49 20504360 - BMC Cancer. 2010 May 26;10 :238 2186486 - Semin Liver Dis. 1990 Feb;10(1):20-9 15690074 - J Clin Invest. 2005 Feb;115(2):209-18 11897564 - Front Biosci. 2002 Apr 01;7:d808-26 23201010 - Biomed Pharmacother. 2013 Apr;67(3):246-50 25753357 - Hepatol Res. 2016 Mar;46(3):E15-25 23305825 - Clin Gastroenterol Hepatol. 2013 Mar;11(3):224-31.e1-5 21803030 - Chem Biol Interact. 2011 Sep 30;193(3):225-31 22245903 - J Hepatol. 2012 May;56(5):1171-80 22295510 - Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Nov;27(4):402-6 25407538 - BMC Complement Altern Med. 2014 Nov 18;14 :449 9300799 - Biochim Biophys Acta. 1997 Aug 22;1361(2):177-84 21057916 - Methods Mol Biol. 2011;682:3-13 25681399 - Gut. 2015 May;64(5):830-41 25618543 - Arch Toxicol. 2015 Mar;89(3):289-317 16009993 - Plant Physiol. 2005 Jul;138(3):1177-84 9691091 - J Clin Invest. 1998 Aug 1;102(3):538-49 21497738 - Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):195-206 28976699 - J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38 8549875 - Digestion. 1995;56(5):335-46 18471545 - Gastroenterology. 2008 May;134(6):1655-69 22971838 - Mol Med Rep. 2012 Dec;6(6):1231-8 12591185 - J Hepatol. 2003;38 Suppl 1:S38-53 18984475 - Clin Liver Dis. 2008 Nov;12(4):939-62, xi 1478568 - Folia Morphol (Warsz). 1992;51(2):109-18 21233278 - Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15 14709595 - Hum Mol Genet. 2004 Feb 15;13(4):429-36 18195085 - Physiol Rev. 2008 Jan;88(1):125-72 |
References_xml | – volume: 264 start-page: 10756 issue: 18 year: 1989 end-page: 10762 ident: CR28 article-title: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix publication-title: J Biol Chem – volume: 25 start-page: 195 issue: 2 year: 2011 end-page: 206 ident: CR6 article-title: Mechanisms of hepatic fibrogenesis publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2011.02.005 – volume: 300 start-page: G709 issue: 5 year: 2011 end-page: G715 ident: CR16 article-title: Therapeutic targets in liver fibrosis publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00451.2010 – volume: 13 start-page: S33 year: 1998 end-page: S38 ident: CR23 article-title: Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis publication-title: J Gastroenterol Hepatol – volume: 682 start-page: 3 year: 2011 end-page: 13 ident: CR33 article-title: In situ detection of apoptosis by the TUNEL assay: an overview of techniques publication-title: Methods Mol Biol doi: 10.1007/978-1-60327-409-8_1 – volume: 13 start-page: 19 issue: 1 year: 2002 end-page: 26 ident: CR21 article-title: Control of differentiation and apoptosis of human myeloid leukemia cell by cytokinins and cytokinin nucleosides, plant redifferentiatian—inducing hormones publication-title: Cell Growth Differ – volume: 138 start-page: 1177 issue: 3 year: 2005 end-page: 1184 ident: CR17 article-title: 1955: Kinetin Arrives. The 50th Anniversary of a New Plant Hormone publication-title: Plant Physiol doi: 10.1104/pp.104.900160 – volume: 67 start-page: 246 issue: 3 year: 2013 end-page: 250 ident: CR34 article-title: Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2012.10.002 – volume: 56 start-page: 1171 issue: 5 year: 2012 end-page: 1180 ident: CR9 article-title: Clinical evidence for the regression of liver fibrosis publication-title: J Hepatol doi: 10.1016/j.jhep.2011.09.024 – volume: 6 start-page: 1231 issue: 6 year: 2012 end-page: 1238 ident: CR13 article-title: The Salvia miltiorrhiza monomer IH764–3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis publication-title: Mol Med Rep – year: 2015 ident: CR30 article-title: Identification of Antrodin B from Antrodia camphorata as a new anti-hepatofibrotic compound using a rapid cell screening method and biological evaluation publication-title: Hepatol Res – volume: 25 issue: 3 year: 2009 ident: CR7 publication-title: Curr Opin Gastroenterol – volume: 12 start-page: 939 issue: 4 year: 2008 end-page: 962 ident: CR11 article-title: Current and future anti-fibrotic therapies for chronic liver disease publication-title: Clin Liver Dis doi: 10.1016/j.cld.2008.07.011 – volume: 18 start-page: 449 issue: 11 year: 2014 end-page: 462 ident: CR29 article-title: Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis publication-title: BMC Complement Altern Med doi: 10.1186/1472-6882-14-449 – volume: 11 start-page: 224 issue: 3 year: 2013 end-page: 231 ident: CR10 article-title: Translating and understanding of the pathogenesis of hepatic fibrosis to novel therapies publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.01.005 – volume: 10 start-page: 238 year: 2010 end-page: 252 ident: CR31 article-title: Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways publication-title: BMC Cancer doi: 10.1186/1471-2407-10-238 – volume: 7 start-page: d808 issue: 4 year: 2002 end-page: d826 ident: CR3 article-title: Activation of hepatic stellate cells—a key issue in liver fibrosis publication-title: Front Biosci doi: 10.2741/reeves – volume: 134 start-page: 1655 issue: 6 year: 2008 end-page: 1669 ident: CR4 article-title: Mechanisms of hepatic fibrogenesis publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.03.003 – volume: 88 start-page: 125 issue: 1 year: 2008 end-page: 172 ident: CR5 article-title: Hepatic stellate cells: protean, multifunctional and enigmatic cells of the liver publication-title: Physiol Rev doi: 10.1152/physrev.00013.2007 – volume: 115 start-page: 209 issue: 2 year: 2005 end-page: 218 ident: CR2 article-title: Liver fibrosis publication-title: J Clin Invest doi: 10.1172/JCI24282 – volume: 13 start-page: 429 issue: 4 year: 2004 end-page: 436 ident: CR20 article-title: Rescue of a human mRNA splicing defect by the plant cytokinin kinetin publication-title: Hum Mol Genet doi: 10.1093/hmg/ddh046 – volume: 51 start-page: 109 issue: 2 year: 1992 end-page: 118 ident: CR18 article-title: Influence of kinetin (6-furfurylo-aminopurine) on human fibroblasts in the cell culture publication-title: Folia Morphol (Warsz) – volume: 193 start-page: 225 issue: 3 year: 2011 end-page: 231 ident: CR1 article-title: Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches publication-title: Chem Biol Interaction doi: 10.1016/j.cbi.2011.07.001 – volume: 10 start-page: 20 issue: 1 year: 1990 end-page: 29 ident: CR26 article-title: Cellular sources of collagen and regulation of collagen production in liver publication-title: Semin Liver Dis doi: 10.1055/s-2008-1040454 – volume: 36 start-page: 131 issue: 3 year: 2003 end-page: 149 ident: CR32 article-title: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer publication-title: Cell Prolif doi: 10.1046/j.1365-2184.2003.00266.x – volume: 27 start-page: 402 issue: 4 year: 2011 end-page: 406 ident: CR12 article-title: The role of extracellular signal-regulated kinase in induction of apoptosis with salvia miltiorrhiza monomer IH764–3 in hepatic stellate cells publication-title: Zhongguo Ying Yong Sheng Li Xue Za Zhi (Chinese) – volume: 64 start-page: 830 issue: 5 year: 2015 end-page: 841 ident: CR14 article-title: Pathobiology of liver fibrosis: a translational success story publication-title: Gut doi: 10.1136/gutjnl-2014-306842 – volume: 102 start-page: 538 issue: 3 year: 1998 end-page: 549 ident: CR25 article-title: Meclianisms of spontaneous resolution of rat liver fibrosis publication-title: Clin Invest doi: 10.1172/JCI1018 – volume: 1361 start-page: 177 issue: 2 year: 1997 end-page: 184 ident: CR24 article-title: Accelerated development of liver fibrosis in CCl4 —treated rats by the weekly induction of acute phase response episodes:upregulation of alpha1(I) procollagen and tissue inhibitor of metalloproteinase-1 mRNAs publication-title: Biochim Biophys Acta doi: 10.1016/S0925-4439(97)00028-8 – volume: 38 start-page: S38 issue: 1 year: 2003 end-page: S53 ident: CR15 article-title: Liver fibrosis-from bench to bedside publication-title: J Hepatol doi: 10.1016/S0168-8278(02)00429-4 – volume: 56 start-page: 335 issue: 5 year: 1995 end-page: 346 ident: CR27 article-title: Molecular mechanisms of liver fibrogenesis—a homage to the role of activated fat— storing cells publication-title: Digestion doi: 10.1159/000201257 – volume: 14 start-page: 780 issue: 10 year: 2006 end-page: 782 ident: CR22 article-title: Effect of kinetin on expression of collagen type I, III, IV and transforming growth factor beta-1 in livers of rats with hepatic fibrosis publication-title: Zhonghua Gan Zang Bing Za Zhi (Chinese) – volume: 465 start-page: 281 issue: 3 year: 2003 end-page: 287 ident: CR19 article-title: Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01528-0 – volume: 89 start-page: 289 issue: 3 year: 2015 end-page: 317 ident: CR35 article-title: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update publication-title: Arch Toxicol doi: 10.1007/s00204-014-1448-7 – volume: 4 issue: 3 year: 2002 ident: CR8 publication-title: Med Gen Med – volume: 7 start-page: d808 issue: 4 year: 2002 ident: 1488_CR3 publication-title: Front Biosci doi: 10.2741/reeves – volume: 1361 start-page: 177 issue: 2 year: 1997 ident: 1488_CR24 publication-title: Biochim Biophys Acta doi: 10.1016/S0925-4439(97)00028-8 – volume: 13 start-page: 429 issue: 4 year: 2004 ident: 1488_CR20 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddh046 – volume: 13 start-page: S33 year: 1998 ident: 1488_CR23 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.1998.13.s1.33 – volume: 10 start-page: 20 issue: 1 year: 1990 ident: 1488_CR26 publication-title: Semin Liver Dis doi: 10.1055/s-2008-1040454 – volume: 300 start-page: G709 issue: 5 year: 2011 ident: 1488_CR16 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00451.2010 – volume: 64 start-page: 830 issue: 5 year: 2015 ident: 1488_CR14 publication-title: Gut doi: 10.1136/gutjnl-2014-306842 – volume: 88 start-page: 125 issue: 1 year: 2008 ident: 1488_CR5 publication-title: Physiol Rev doi: 10.1152/physrev.00013.2007 – volume: 4 issue: 3 year: 2002 ident: 1488_CR8 publication-title: Med Gen Med – volume: 18 start-page: 449 issue: 11 year: 2014 ident: 1488_CR29 publication-title: BMC Complement Altern Med doi: 10.1186/1472-6882-14-449 – volume: 115 start-page: 209 issue: 2 year: 2005 ident: 1488_CR2 publication-title: J Clin Invest doi: 10.1172/JCI24282 – volume: 13 start-page: 19 issue: 1 year: 2002 ident: 1488_CR21 publication-title: Cell Growth Differ – volume: 36 start-page: 131 issue: 3 year: 2003 ident: 1488_CR32 publication-title: Cell Prolif doi: 10.1046/j.1365-2184.2003.00266.x – volume: 56 start-page: 1171 issue: 5 year: 2012 ident: 1488_CR9 publication-title: J Hepatol doi: 10.1016/j.jhep.2011.09.024 – volume: 134 start-page: 1655 issue: 6 year: 2008 ident: 1488_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.03.003 – volume: 102 start-page: 538 issue: 3 year: 1998 ident: 1488_CR25 publication-title: Clin Invest doi: 10.1172/JCI1018 – volume: 11 start-page: 224 issue: 3 year: 2013 ident: 1488_CR10 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.01.005 – volume: 465 start-page: 281 issue: 3 year: 2003 ident: 1488_CR19 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01528-0 – volume: 264 start-page: 10756 issue: 18 year: 1989 ident: 1488_CR28 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)81686-6 – volume: 25 issue: 3 year: 2009 ident: 1488_CR7 publication-title: Curr Opin Gastroenterol – volume: 67 start-page: 246 issue: 3 year: 2013 ident: 1488_CR34 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2012.10.002 – volume: 14 start-page: 780 issue: 10 year: 2006 ident: 1488_CR22 publication-title: Zhonghua Gan Zang Bing Za Zhi (Chinese) – volume: 12 start-page: 939 issue: 4 year: 2008 ident: 1488_CR11 publication-title: Clin Liver Dis doi: 10.1016/j.cld.2008.07.011 – volume: 138 start-page: 1177 issue: 3 year: 2005 ident: 1488_CR17 publication-title: Plant Physiol doi: 10.1104/pp.104.900160 – volume: 27 start-page: 402 issue: 4 year: 2011 ident: 1488_CR12 publication-title: Zhongguo Ying Yong Sheng Li Xue Za Zhi (Chinese) – volume: 38 start-page: S38 issue: 1 year: 2003 ident: 1488_CR15 publication-title: J Hepatol doi: 10.1016/S0168-8278(02)00429-4 – volume: 56 start-page: 335 issue: 5 year: 1995 ident: 1488_CR27 publication-title: Digestion doi: 10.1159/000201257 – volume: 51 start-page: 109 issue: 2 year: 1992 ident: 1488_CR18 publication-title: Folia Morphol (Warsz) – volume: 10 start-page: 238 year: 2010 ident: 1488_CR31 publication-title: BMC Cancer doi: 10.1186/1471-2407-10-238 – volume: 6 start-page: 1231 issue: 6 year: 2012 ident: 1488_CR13 publication-title: Mol Med Rep doi: 10.3892/mmr.2012.1076 – volume-title: Hepatol Res year: 2015 ident: 1488_CR30 – volume: 682 start-page: 3 year: 2011 ident: 1488_CR33 publication-title: Methods Mol Biol doi: 10.1007/978-1-60327-409-8_1 – volume: 25 start-page: 195 issue: 2 year: 2011 ident: 1488_CR6 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2011.02.005 – volume: 193 start-page: 225 issue: 3 year: 2011 ident: 1488_CR1 publication-title: Chem Biol Interaction doi: 10.1016/j.cbi.2011.07.001 – volume: 89 start-page: 289 issue: 3 year: 2015 ident: 1488_CR35 publication-title: Arch Toxicol doi: 10.1007/s00204-014-1448-7 – reference: 16009993 - Plant Physiol. 2005 Jul;138(3):1177-84 – reference: 14709595 - Hum Mol Genet. 2004 Feb 15;13(4):429-36 – reference: 9691091 - J Clin Invest. 1998 Aug 1;102(3):538-49 – reference: 11897564 - Front Biosci. 2002 Apr 01;7:d808-26 – reference: 12814430 - Cell Prolif. 2003 Jun;36(3):131-49 – reference: 21497738 - Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):195-206 – reference: 23201010 - Biomed Pharmacother. 2013 Apr;67(3):246-50 – reference: 11801528 - Cell Growth Differ. 2002 Jan;13(1):19-26 – reference: 12681440 - Eur J Pharmacol. 2003 Apr 4;465(3):281-7 – reference: 23305825 - Clin Gastroenterol Hepatol. 2013 Mar;11(3):224-31.e1-5 – reference: 2186486 - Semin Liver Dis. 1990 Feb;10(1):20-9 – reference: 18984475 - Clin Liver Dis. 2008 Nov;12(4):939-62, xi – reference: 25681399 - Gut. 2015 May;64(5):830-41 – reference: 2732246 - J Biol Chem. 1989 Jun 25;264(18):10756-62 – reference: 18471545 - Gastroenterology. 2008 May;134(6):1655-69 – reference: 28976699 - J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38 – reference: 22245903 - J Hepatol. 2012 May;56(5):1171-80 – reference: 25407538 - BMC Complement Altern Med. 2014 Nov 18;14 :449 – reference: 21803030 - Chem Biol Interact. 2011 Sep 30;193(3):225-31 – reference: 25753357 - Hepatol Res. 2016 Mar;46(3):E15-25 – reference: 22295510 - Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Nov;27(4):402-6 – reference: 8549875 - Digestion. 1995;56(5):335-46 – reference: 15690074 - J Clin Invest. 2005 Feb;115(2):209-18 – reference: 17064479 - Zhonghua Gan Zang Bing Za Zhi. 2006 Oct;14(10):780-2 – reference: 25618543 - Arch Toxicol. 2015 Mar;89(3):289-317 – reference: 21233278 - Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15 – reference: 21057916 - Methods Mol Biol. 2011;682:3-13 – reference: 9300799 - Biochim Biophys Acta. 1997 Aug 22;1361(2):177-84 – reference: 22971838 - Mol Med Rep. 2012 Dec;6(6):1231-8 – reference: 20504360 - BMC Cancer. 2010 May 26;10 :238 – reference: 12591185 - J Hepatol. 2003;38 Suppl 1:S38-53 – reference: 1478568 - Folia Morphol (Warsz). 1992;51(2):109-18 – reference: 18195085 - Physiol Rev. 2008 Jan;88(1):125-72 |
SSID | ssj0057624 |
Score | 1.6667829 |
Snippet | Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality.... Summary Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and... Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality.... |
SourceID | wanfang pubmed crossref springer chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 672 |
SubjectTerms | Animals Apoptosis - drug effects bcl-2-Associated X Protein - agonists bcl-2-Associated X Protein - genetics bcl-2-Associated X Protein - metabolism Bcl-2/Bax Cell Line, Transformed Cell Proliferation - drug effects Dose-Response Relationship, Drug G1 Phase Cell Cycle Checkpoints - drug effects G1 Phase Cell Cycle Checkpoints - genetics Gene Expression Regulation Growth Inhibitors - pharmacology Hepatic Stellate Cells - cytology Hepatic Stellate Cells - drug effects Hepatic Stellate Cells - metabolism Kinetin - pharmacology Medicine Medicine & Public Health Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism Rats Signal Transduction 比值 激动素 细胞凋亡 细胞周期 细胞增殖 肝纤维化 诱导凋亡 |
Title | Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax |
URI | http://lib.cqvip.com/qk/85740A/201505/666317658.html https://link.springer.com/article/10.1007/s11596-015-1488-0 https://www.ncbi.nlm.nih.gov/pubmed/26489620 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201505010 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: U2A dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZgKyEuUN5LaeVDTyCXvOwmxy1qqajKqSuVU-RXdtNWTthkxS5_gr_MTF5bKlSpp0jxeJxoJvY3mRch-4ZzbnylmMLcj8gkMZNeYlgcyUPj2SizTZGk8-_idBp9u-SXXR531Ue79y7JZqfeJLvByYvWL2cA4WMGdvoWR_tkRLYmX3-cHfcbMCDotpetOMTAyjDsnZn_Y4IlFeaFm_2EBf85mobzaHCQNmk9LpNudusEOnlOLvpnbwNPrg-WtTrQv--UdXzgy22TZx0ipZNWhV6QR9a9JE_OO5_7K_LnDC517mju5rnK64qW2Okns63u0CKjc4tx2ZpWmJIC4JWiO6Ciak2xGsVisSwxuLq5S_UaVqHSGRgzoFcVlWVR1kWVNxNM8cuxhZ01XcVgTrMIrnGkb1jw-UiuXpPpyfHFl1PWtXFgGqzFmmnP-DbmnhUa_b4y8I1WUtjYk9qLo4irJFaJFp4KQ24Ar8aJnykeGbDklNYmfENGrnD2HaFApSMrfIHIw4SxDJXMEtiHLNi5Uogx2RmkmZZtuY4UDDQASYC0xsTr5ZvqrgI6NuK4STe1m1EMKYghRTGk3ph8HKb0_O4hftsqzUCK4YOJCGDkUy_2tNsjqvv47HeKtiGur9bXZrVSqQ3wHxUHM_r9g5jukKdBo14Yh_iBjOrF0u4CnqrVXvf97JHH02DyFyO0Ft0 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbQVgIuvClLefjQE8glD9t1ji1qWdhuT1upnCy_shtaJWGTFbv8Cf4y4zx2AaFKPUWKx-NEM7G_ybwQ2reMMRtqTbTP_aA2EUQFiSWCqkMbOJq6pkjS5JyPLuiXS3bZ5XFXfbR775JsduptshucvN76ZQQgvCBgp-_QUAg6QDtHn76OT_oNGBB028uWH_rAyjjunZn_Y-JLKsyLfPYdFvzraNqcRxsHaZPWk6cqn_1xAp0-RNP-2dvAk6uDZa0PzM9_yjre8uUeoQcdIsVHrQo9Rndc_gTdnXQ-96fo1xgudZbjLJ9nOqsrXPpOP6lrdQcXKZ47H5dtcOVTUgC8Yu8OqLBeY1-NYrFYlj64urmLzRpWwSq3MGZBryqsyqKsiyprJtjiR04WbtZ0FYM5zSJ-jWNzTaIPx2r1DF2cnkw_jkjXxoEYsBZrYgIbOsECx433-6ootEYr7kSgTCAoZToROjE80HHMLOBVkYSpZtSCJaeNsfFzNMiL3L1AGKgMdTzkHnnYWKhYqzSBfciBnas4H6K9jTRl2ZbrkGCgAUgCpDVEQS9faboK6L4Rx7Xc1m72YpAgBunFIIMhereZ0vO7gXi3VZoNqQ8fTHgEI-97sctuj6hu4rPfKdqWuP62vrKrlZYu8v-oGJjRL2_F9C26N5pOzuTZ5_PxHrofNarmYxJfoUG9WLrXgK1q_ab7ln4D3DUY5Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLZQkSouiJ2hLD70BLImi-0mxxYYFUorDozUm-UtnUDlhEkqzfwK_jLvZRuQUCVOkeJNynP8vs9vI-TQCSFcbAwzGPvBXZ4xHeWOZVwfucjzwndJks4v5OmSf74Ul0Od02b0dh9Nkn1MA2ZpCu28dsV8F_gGWhiZsGAA5zMGnP0uB1WN7GuZHI9HMWDpvqqtPEIXyzQdzZr_mgKTK6yqcPUTlv5LSU2aaTKVdgE-odDh6g9dtHhA7g8gkh73Un9I7vjwiOyfD2byx-TXGTzaMtAyrEpTtg2tsThP4Xtx06qgK4-u1JY2GEUCeJPiDX5DzZZiAon1-qZGf-juLbVbWIXq4KDNwVZoqK6ruq2ashvggMizdV_THsd0i-AaJ_aaJfMTvXlClouP396fsqHyArNA8FpmIxf7TEReWjTV6iR21mjps0jbKONcmDwzuZWRSVPhAGJmeVwYwR2QL2OtS5-SvVAF_5xQ6GW5l7FEsODSTKdGFzkcHR6oqZZyRg6mz67qPsOGAk4FuAbA0YxEoyCUHZKWY-2Ma7VLt4xyVCBHhXJU0Yy8nYaM893S-Vkv3akrevzlMoGWd6O41fBbN7fNczjsiF3n9vv2h9tsjPIJXisJYL4v_mvSN2T_64eF-vLp4uyA3Eu6rYpehC_JXru-8a8ADbXmdbfjfwMCVwBZ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kinetin+inhibits+proliferation+of+hepatic+stellate+cells+by+interrupting+cell+cycle+and+induces+apoptosis+by+down-regulating+ratio+of+Bcl-2%2FBax&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Zhang%2C+Zhen-Gang&rft.au=Zou%2C+Jie&rft.au=Huang%2C+Ying&rft.au=Wu%2C+Liang&rft.date=2015-10-01&rft.eissn=1993-1352&rft.volume=35&rft.issue=5&rft.spage=672&rft_id=info:doi/10.1007%2Fs11596-015-1488-0&rft_id=info%3Apmid%2F26489620&rft.externalDocID=26489620 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |